AMERSHAM, United Kingdom, Feb. 1, 2021 /PRNewswire/ -- Cytiva has acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges ...
A new robotic vial filling machine for clinical trials and product development of biopharmaceuticals, cell therapies and personalized medicines. Microcell makes it cost-effective and easy to add small ...
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to ...
New York, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Dual Chamber Syringe Filling Machine Market Research Report by Type, by Application - Global Forecast ...
(MENAFNEditorial) Vancouver, Canada and Mumbai, India March 15, 2018 SCHOTT KAISHA and Vanrx Pharmasystems are announcing compatibility between SCHOTT KAISHAs ready-to-use nested syringes, cartridges ...
Robotic fill/finish systems reduce human intervention, improve flexibility, and allow more gentle handling of containers. The population of robots working on parenteral fill/finish lines is increasing ...
"India's pharmaceutical sector will grow to its greatest potential by using flexible manufacturing technologies that enhance competitiveness. Indian companies are investing in biosimilars and complex ...
Cytiva acquired Vanrx Pharmasystems, a Canadian company that makes robotic aseptic filling machines to fill vials, syringes, and cartridges. The deal marks the first acquisition by Cytiva. “Since ...
RAMSEY, N.J. and BOCA RATON, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to ...
A new robotic vial filling machine for clinical trials and product development of biopharmaceuticals, cell therapies and personalized medicines. Microcell makes it cost-effective and easy to add small ...
The population of robots working on parenteral fill/finish lines is increasing rapidly. The expansion mirrors growth in biotech products, particularly self-injected therapies, which require ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results